Patents by Inventor Angelika ELLERMANN

Angelika ELLERMANN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230000778
    Abstract: A scored tablet comprises Tapentadol or a physiologically acceptable salt thereof embedded in a prolonged release matrix material; wherein the scored tablet provides prolonged release of Tapentadol or the physiologically acceptable salt thereof; wherein the scored tablet has a site of mechanical weakness along which it can be manually broken into two separate halves preferably having essentially the same size, shape and weight; and wherein the in vitro release profile of the scored tablet essentially corresponds to the in vitro release profile of each of the two separate halves. Also disclosed is a process for the preparation of such a scored tablet.
    Type: Application
    Filed: September 14, 2022
    Publication date: January 5, 2023
    Applicant: GRUENENTHAL GMBH
    Inventors: Angelika ELLERMANN, Ulrike BERTRAM, Gerd BARTZ, Udo RUETTGERS
  • Patent number: 10898452
    Abstract: The invention relates to an an aqueous pharmaceutical composition for parenteral administration comprising Tapentadol or a physiologically acceptable salt thereof; wherein the concentration of Tapentadol is greater than 8.00 mg/mL, based on the weight of Tapentadol free base and based on the total volume of the composition; wherein the composition comprises a buffer system; and wherein the pH value of the composition is within the range of from greater than 3.0 to less than 6.7. The invention also relates to a kit comprising the composition according to the invention in a packaging. The pharmaceutical composition according to the invention is particularly useful for treating pain, especially acute pain, preferably in adult patients.
    Type: Grant
    Filed: September 22, 2017
    Date of Patent: January 26, 2021
    Assignee: GRUENENTHAL GMBH
    Inventors: Angelika Ellermann, Ulrich Reinhold, Ulrike Bertram
  • Publication number: 20180085328
    Abstract: The invention relates to an an aqueous pharmaceutical composition for parenteral administration comprising Tapentadol or a physiologically acceptable salt thereof; wherein the concentration of Tapentadol is greater than 8.00 mg/mL, based on the weight of Tapentadol free base and based on the total volume of the composition; wherein the composition comprises a buffer system; and wherein the pH value of the composition is within the range of from greater than 3.0 to less than 6.7. The invention also relates to a kit comprising the composition according to the invention in a packaging. The pharmaceutical composition according to the invention is particularly useful for treating pain, especially acute pain, preferably in adult patients.
    Type: Application
    Filed: September 22, 2017
    Publication date: March 29, 2018
    Inventors: Angelika ELLERMANN, Ulrich REINHOLD, Ulrike BERTRAM